Award/Contract W81XWH-15-0101 modification dated July 31, 2020 issued by USA Med Research ACQ Activity

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

1. CONTRACT ID CODE

U

PAGE OF PAGES

 1    4

 2.  AMENDMENT/MODIFICATION NO.

 3.  EFFECTIVE DATE

31-Jul-2020

 4. REQUSITION/PURCHASE REQ. NO.

0010624278-0002

 5. PROJECT NO. (If applicable)

 6.  ISSUED BY                            CODE

W81XWH

7. ADMINISTERED BY (If other than Remo)        CODE           W81XWH

USA MED RESEARCH ACQ ACTIVITY

820 CHANDLER ST

    FORT DETRICK MD ###-###-####

USA MED RESEARCH ACO ACTIVITY

820 CHANDLER ST

FORT DETRICK MD ###-###-####

 8.  NAME AND ADDRESS OF CONTRACTOR (No., Street, County, State and Zip Code)

CLEVELAND BIOLABS, INC.

CLEVELAND BIOLABS

73 HIGH ST STE 203A

BUFFALO NY14203-1149

9A. AMENDMENT OF SOLICITATION NO.

9B. DATED (SEE ITEM 11)

X

10A. MOD. OF CONTRACT/ORDER NO.

W81XWH-15-C-0101

X

10B. DATED (SEE ITEM 13)

17-Aug-2015

CODE 3MWX2

FACILITY CODE

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

☐

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offer ☒ is extended, ☐ is not extended.

Offer must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended by one of the following methods: (a) By completing Items 8 and 15, and returning ___ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

12.  ACCOUNTING AND APPROPRIATION DATA (If required)

  See Schedule

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACT/ORDERS.
IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE 1N THE CONTRACT ORDER NO. IN ITEM 10A.

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(B).

x

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

FAR 52.243-2 - Changes Cost-Reimbursement

D. OTHER (Specify type of modification and authority)

E. IMPORTANT: Contractor

☐ is not, ☒ is required to sign this document and return 1 copy to the issuing office.

 14.  DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

Modification Control Number: pmartha203261

The purpose of this modification is as follows:

Revise the current scope of work.

Re-budget CLIN 0001 funds for mouse model assay; as well as, biocomparability study.

De-obligate cancelling funds for return to the US Department of Treasury.

Revise the period of performance.

All other terms and conditions remain unchanged. Please see continuation page for further information.

Except as provided herein, all terms and conditions of the document referenced in Item9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER (Type or print)

Christopher Zosh, VP of Finance

16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

Medina.Wayn (Digitally signed by Medina.Wayn.A – E.A. 1376454181)

TEL EMAIL

15B. CONTRACTOR/OFFEROR

(Signature of person authorized to sign)

15C. DATE SIGNED

7/29/20

16B. UNITED STATES OF AMERICA

_____________________________________________

(Signature of Contracting Officer)

16C. DATE SIGNED

7/30/20